Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Glaxo shares slump amid concerns over its vaccine pipeline of new drugs as patent losses loom

The pharmaceutical giant reported beat third-quarter sales and profit expectations, driven by a 15% rise in demand for its specialty HIV and respiratory medicines.

Glaxo shares slump amid concerns over its vaccine pipeline of new drugs as patent losses loom

We haven't written up this one. This Is Money has the full story — the link below goes straight to it.

Read the original at thisismoney.co.uk →

More in Health & Medicine

More from Wednesday 28 October →